Progress towards the 'Golden Age' of biotechnology

Kevan Gartland; Fabrizio Bruschi; M. Dundar; P.B. Gahan; M.P. Viola-Magni; Y. Akbarova

doi:10.1016/j.copbio.2013.05.011

Progress towards the 'Golden Age' of biotechnology

Kevan Gartland, Fabrizio Bruschi, M. Dundar, P.B. Gahan, M.P. Viola-Magni, Y. Akbarova

Research output: Contribution to journal › Article › peer-review

22 Citations (Scopus)

Abstract

Biotechnology uses substances, materials or extracts derived from living cells, employing 22 million Europeans in a €1.5Tn endeavour, being the premier global economic growth opportunity this century. Significant advances have been made in red biotechnology using pharmaceutically and medically relevant applications, green biotechnology developing agricultural and environmental tools and white biotechnology serving industrial scale uses, frequently as process feedstocks.

Original language	English
Journal	Current Opinion in Biotechnology
Volume	24
Early online date	23 Jun 2013
DOIs	https://doi.org/10.1016/j.copbio.2013.05.011
Publication status	Published - 2013

Keywords

biotechnology
Europe

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Documents and Links

10.1016/j.copbio.2013.05.011

http://authors.elsevier.com/sd/article/S0958166913001274

Cite this

@article{60636a7cdc474311a54642844acc4c2a,

title = "Progress towards the 'Golden Age' of biotechnology",

abstract = "Biotechnology uses substances, materials or extracts derived from living cells, employing 22 million Europeans in a €1.5Tn endeavour, being the premier global economic growth opportunity this century. Significant advances have been made in red biotechnology using pharmaceutically and medically relevant applications, green biotechnology developing agricultural and environmental tools and white biotechnology serving industrial scale uses, frequently as process feedstocks. ",

keywords = "biotechnology, Europe",

author = "Kevan Gartland and Fabrizio Bruschi and M. Dundar and P.B. Gahan and M.P. Viola-Magni and Y. Akbarova",

note = "Check back for print version details ET 1-7-13",

year = "2013",

doi = "10.1016/j.copbio.2013.05.011",

language = "English",

volume = "24",

journal = "Current Opinion in Biotechnology",

issn = "0958-1669",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Progress towards the 'Golden Age' of biotechnology

AU - Gartland, Kevan

AU - Bruschi, Fabrizio

AU - Dundar, M.

AU - Gahan, P.B.

AU - Viola-Magni, M.P.

AU - Akbarova, Y.

N1 - Check back for print version details ET 1-7-13

PY - 2013

Y1 - 2013

N2 - Biotechnology uses substances, materials or extracts derived from living cells, employing 22 million Europeans in a €1.5Tn endeavour, being the premier global economic growth opportunity this century. Significant advances have been made in red biotechnology using pharmaceutically and medically relevant applications, green biotechnology developing agricultural and environmental tools and white biotechnology serving industrial scale uses, frequently as process feedstocks.

AB - Biotechnology uses substances, materials or extracts derived from living cells, employing 22 million Europeans in a €1.5Tn endeavour, being the premier global economic growth opportunity this century. Significant advances have been made in red biotechnology using pharmaceutically and medically relevant applications, green biotechnology developing agricultural and environmental tools and white biotechnology serving industrial scale uses, frequently as process feedstocks.

KW - biotechnology

KW - Europe

U2 - 10.1016/j.copbio.2013.05.011

DO - 10.1016/j.copbio.2013.05.011

M3 - Article

VL - 24

JO - Current Opinion in Biotechnology

JF - Current Opinion in Biotechnology

SN - 0958-1669

ER -

Progress towards the 'Golden Age' of biotechnology

Abstract

Keywords

UN SDGs

Documents and Links

Fingerprint

Cite this